PMBL

Clinical trials for PMBL explained in plain language.

Never miss a new study

Get alerted when new PMBL trials appear

Sign up with your email to follow new studies for PMBL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

A CAR-T therapy given by injection: can it help Hard-to-Treat lymphoma?

Cure Recruiting now

Researchers are testing a new CAR-T cell therapy called C402-CD19-CAR in adults with large B-cell lymphoma that has come back or stopped responding to treatment. The therapy is made from each participant's own T cells, which are modified to target CD19, a marker on lymphoma cells…

Matched conditions: PMBL

Phase 1 • Sponsor: Shanghai Exuma Biotechnology Ltd. • Aim: Cure

Last updated Sep 13, 2026 00:00 UTC

PMBL

Get alerted when new PMBL trials appear

A CAR-T therapy given by injection: can it help Hard-to-Treat lymphoma?